Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ideaya Biosciences
Biotech
Amgen and Ideaya ax cancer combination trial
Amgen and Ideaya mutually agreed to wind the current study down and drop plans to start dose expansion.
Nick Paul Taylor
Feb 13, 2025 7:34am
BeiGene, Brii and Ideaya ring in 2025 with deals
Jan 2, 2025 8:30am
Ideaya pushes ahead with Biocytogen bispecific ADC bet
Nov 11, 2024 8:50am
Black Diamond, Ideaya mull registrational trials for cancer meds
Sep 23, 2024 12:18pm
Ideaya bags option on Biocytogen bispecific ADC in $400M deal
Jul 31, 2024 9:04am
Roche, Vir, Neurocrine & more—Chutes & Ladders
May 31, 2024 8:30am
